Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ACHE | P22303 | 2/20 | 0.56 |
| ▸ | LMNA | P02545 | 3/20 | 0.52 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.43 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.43 |
| ▸ | GAA | P10253 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.42 |
| ▸ | AR | P10275 | 2/20 | 0.40 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.40 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | LYN | P07948 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8151669 | 0.84 | KMT2A (0.41) | ACHELMNAALDH1A1TDP1GAA | |
| SCHEMBL12916666 | 0.78 | ACHE (0.56) | ACHELMNAALDH1A1HTTTDP1 | |
| SCHEMBL15421219 | 0.78 | ACHE (0.56) | ACHELMNAALDH1A1HTTTDP1 | |
| SCHEMBL4179729 | 0.78 | ACHE (0.56) | ACHELMNAALDH1A1HTTTDP1 | |
| SCHEMBL98035 | 0.78 | ACHE (0.50) | ACHELMNAALDH1A1KMT2A | |
| SCHEMBL9280504 | 0.77 | ACHE (0.54) | ACHELMNAALDH1A1HTTTDP1 | |
| SCHEMBL2496298 | 0.77 | CYP2A6 (0.54) | ACHELMNAALDH1A1TDP1GAA | |
| SCHEMBL30692443 | 0.77 | ACHE (0.54) | ACHELMNAALDH1A1HTTTDP1 | |
| SCHEMBL1190705 | 0.77 | ALDH1A1 (0.46) | LMNAALDH1A1TDP1MAPTKMT2A | |
| SCHEMBL17372842 | 0.75 | ACHE (0.76) | ACHELMNAALDH1A1HTTTDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 568 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1730152-A2 | TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME | TANABE SEIYAKU CO., LTD. (JP) | 2006-12-13 | — | — | EP | claimed |
| WO-2005095409-A2 | TETRAHYDROQUINOLINE DERIVATIVES AND A PROCESS FOR PREPARING THE SAME | TANABE SEIYAKU CO., LTD. (JP) | 2005-10-13 | — | — | WO | claimed |
| EP-0354297-B1 | THIADIAZINES, PROCESS FOR PRODUCTION THEREOF, AND INSECTICIDAL AND ACARICIDAL AGENTS COMPRISING THE THIADIAZINES | MITSUI TOATSU CHEMICALS, Inc. (JP) | 1992-08-05 | — | — | EP | claimed |
| US-12034115-B2 | Solid electrolyte composition, sheet for all-solid state secondary battery, electrode sheet for all-solid state secondary battery, and all-solid state secondary battery | FUJIFILM CORPORATION (JP) | 2024-07-09 | — | — | US | disclosed |
| CN-114175339-B | Composition containing inorganic solid electrolyte, sheet for all-solid-state secondary battery and all-solid-state secondary battery, and method for producing sheet for all-solid-state secondary battery and all-solid-state secondary battery | 富士胶片株式会社 | 2024-07-02 | — | — | CN | disclosed |
| US-20240213479-A1 | ELECTRODE COMPOSITION, ELECTRODE SHEET FOR ALL-SOLID STATE SECONDARY BATTERY, ALL-SOLID STATE SECONDARY BATTERY, AND MANUFACTURING METHODS FOR ELECTRODE COMPOSITION, ELECTRODE SHEET FOR ALL-SOLID STATE SECONDARY BATTERY, AND ALL-SOLID STATE SECONDARY BATTERY | FUJIFILM CORPORATION (JP) | 2024-06-27 | — | — | US | disclosed |
| US-20240186606-A1 | SEPARATION RECOVERY METHOD OF METAL IONS, AND TWO-PHASE SEPARATED FLUID | FUJIFILM CORPORATION (JP) | 2024-06-06 | — | — | US | disclosed |
| CN-118077019-A | Inorganic solid electrolyte-containing composition, sheet for all-solid-state secondary battery and all-solid-state secondary battery, and method for producing sheet for all-solid-state secondary battery and all-solid-state secondary battery | 富士胶片株式会社 | 2024-05-24 | — | — | CN | disclosed |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | ARES CAPITAL CORPORATION, AS AGENT | 2024-05-23 | — | — | US | disclosed |
| US-11987590-B2 | Compounds that participate in cooperative binding and uses thereof | Revolution Medicines, Inc. (US) | 2024-05-21 | — | — | US | disclosed |
| US-20240157329-A1 | ADSORBENT, POLYMER, AND ADSORPTION APPARATUS | FUJIFILM CORPORATION (JP) | 2024-05-16 | — | — | US | disclosed |
| US-4579682-A | HEAT, OXYGEN, AND LIGHT PROTECTION FOR POLYMERS | CIBA-GEIGY CORPORATION (US) | 1986-04-01 | — | — | US | disclosed |
| EP-0158467-A2 | Method for selective methylation of erythromycin a derivatives | TAISHO PHARMACEUTICAL CO. LTD (JP) | 1985-10-16 | — | — | EP | disclosed |
| US-4500622-A | HYDRAZONE COMPOUND, (THIO-)BARBITURIC ACID DERIVATIVE AND BINDER | FUJI PHOTO FILM CO., LTD. | 1985-02-19 | — | — | US | disclosed |
| EP-0042359-B1 | PHOSPHONOUS-ACID MONOESTER MONOAMIDE AND ORGANIC POLYMERS STABILIZED THEREWITH | CIBA-GEIGY AG (CH) | 1984-10-31 | — | — | EP | disclosed |
| US-4469768-A | Electrophotographic light-sensitive material comprising a charge-generating material and a charge-transporting material | FUJI PHOTO FILM CO., LTD. (JP) | 1984-09-04 | — | — | US | disclosed |
| US-4434109-A | STABILIZERS AGAINST HEAT, OXYGEN AND LIGHT | CIBA-GEIGY CORPORATION (US) | 1984-02-28 | — | — | US | disclosed |
| US-4423130-A | HEAT AND LIGHT STABILIZATION; OZONE RESISTANCE; CHARGE TRANSPORT | FUJI PHOTO FILM CO., LTD. (JP) | 1983-12-27 | — | — | US | disclosed |
| EP-0042359-A1 | Phosphonous-acid monoester monoamide and organic polymers stabilized therewith | CIBA-GEIGY AG (CH) | 1981-12-23 | — | — | EP | disclosed |
| US-4259350-A | PROTECTING DEGRADABLE ORGANIC MATERIAL FROM FUNGAL OR INSECT ATTACK | SANKYO COMPANY LIMITED (JP) | 1981-03-31 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11987590-B2 | Compounds that participate in cooperative binding and uses thereof | CEP170, PIN1, FKBP3 | ACHE 4035/4885LMNA 4384/4885ALDH1A1 4800/4885 |
| US-20240165267-A1 | MODIFIED NUCLEIC ACID MOLECULES AND USES THEREOF | NSUN2, ADAR, NSUN3 | ACHE 4868/4885LMNA 422/4885ALDH1A1 1969/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.